
A new study has found the immune system in the blood of Alzheimer’s patients is epigenetically altered. That means the patients’ behavior or environment has caused changes that affect the way their genes work.
A team of researchers has developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions.
Many patients continue to struggle in the wake of the pandemic as they grapple with ongoing symptoms triggered by COVID-19 infection, a condition commonly known as long COVID. However, the onset of symptoms such as brain fog, fatigue, headache, and other types of pain is not unique to COVID infection, according to a new study.
Researchers have discovered a molecular complex crucial for the transport of mitochondria within neurons, offering new insights into preventing neurodegenerative diseases.
A landmark advancement in neural prosthetics has been made, demonstrating the ability to recall specific memories using a newly developed memory decoding model (MDM). The study, involving 14 adults with epilepsy, showed that MDM stimulation significantly improved memory performance, particularly in those with impaired memory, offering hope for treating conditions like Alzheimer’s disease, stroke, or head injury. This research signifies a major step toward creating interventions that can restore lost memory functions, potentially aiding individuals in living more independently.
A new study reveals that excessive stress during adolescence can lead to long-lasting changes in gene expression in the brain, particularly those related to bioenergy functions.
Researchers developed an innovative AI tool, DeepGO-SE, that excels in predicting the functions of unknown proteins, marking a significant advance in bioinformatics. Leveraging large language models and logical entailment, this tool can deduce molecular functions even for proteins without existing database matches, offering a groundbreaking approach to understanding cellular mechanisms.
Researchers have identified cortical gray matter thinning as a potential early biomarker for dementia.
Smoking not only affects immune responses in the short term but also leaves a lasting imprint on the body’s defense mechanisms. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses.
MIT neuroscientists have found that the brain’s sensitivity to rewarding experiences—a critical factor in motivation and attention—can be shaped by socioeconomic conditions.
Taking an anticoagulant, or blood-thinning medication, can increase one’s risk of—or exacerbate—a brain bleed, also known as a brain hemorrhage, which is the deadliest type of stroke. Now, new research finds that faster treatment for these patients is associated with a greater likelihood of survival.
Finally this week, language and culture may influence how our brains process emotional faces according to new research.





